<DOC>
	<DOCNO>NCT01668901</DOCNO>
	<brief_summary>In study , investigator examine whether aspirin warfarin useful atrial fibrillation patient chronic kidney disease .</brief_summary>
	<brief_title>Warfarin Versus Aspirin Patients With Atrial Fibrillation Chronic Kidney Disease</brief_title>
	<detailed_description>randomise open label prospective study We enroll patient CHADS2 score 1 non-valvular AF chronic kidney disease , analyze thromboembolic event major bleed event follow-up period . Warfarin group take dose adjust warfarin ( target INR 2.0-3.0 ) aspirin group take aspirin 100mg daly . Thromboembolic event : Ischemic stroke systemic arterial occlusion Major bleeding : gastrointestinal bleed intracranial bleeding ( code 430 , code 431 , code 432 ICD-9-CM code ) - &gt; Only first event case use analysis</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>CHADS2 score 1 nonvalvular atrial fibrillation patient chronic kidney disease HASBLED â‰¥30 History syncope seizure within 1 year History major bleed event within 6 month BP &gt; 180/100 Abnormal prothrombin time Hypersensitivity aspirin warfarin Folstein mini mental state examination score &lt; 26 Taking take anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>warfarin</keyword>
	<keyword>aspirin</keyword>
</DOC>